AKT1	the serine-threonine protein kinase
ALL	acute lymphoblastic leukemia
BCP-ALL	B-cell precursor acute lymphoblastic leukemia
BSAP	B-cell-specific protein activator factor
CIR	cumulative incidence of relapse
CNAs	copy number alterations
DFR	disease free of recurrence
DIC	disseminated intravascular coagulation
DR	Downregulation
EGIL	The European Group for the Immunologic Classification
ESF	event-free survival
ETP-ALL	Early T-cell precursor ALL
GSI	γ-secretase inhibitors
HD	heterodimerization domain
JAK 1	janus kinase 1
LBL	acute lymphoblastic lymphoma
LDH	lactate dehydrogenase
MRD	minimal residual disease
NGS	new generation sequencing
OE	Overexpression
OS	overall survival
PDGFRb	platelet dderived growth factor b
PEST	(-Pro-Gln-Ser-Thr-) domain.
PIP2	phosphatidylinositol (4,5) P2
PIP3	phosphatidylinositol (3,4,5) P3
PRC	polycomb group complex
RFS	relapse-free survival
SNV	single nucleotide variants
STAT5B	signal transducer and activator of transcription 5B
T-ALL	T-cell acute lymphoblastic leukemia
TCR	T cell antigen receptor
TKI	tyrosine kinase inhibitor
WBC	white blood cell